Walsh, Thomas J.
50 papers on CoChatORCID 0000-0002-4142-8711
Most cited papers
- Verified
Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints
Pfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., et al. (2008) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 250
- Verified
Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal Therapy
Francis, P., & Walsh, T. J. (1992) · Clinical Infectious Diseases
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 232
- Verified · note
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
Espinel-Ingroff, A., Bartlett, M., Bowden, R., Chin, N. X., Cooper, C., Fothergill, A., McGinnis, M. R., Menezes, P., Messer, S. A., Nelson, P. W., et al. (1997) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 228
- Verified
Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study
Espinel-Ingroff, A., Fothergill, A., Peter, J., Rinaldi, M. G., & Walsh, T. J. (2002) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 203
- Verified
Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents
Jacobs, S. E., Jacobs, J. L., Dennis, E. K., Taimur, S., Rana, M., Patel, D., Gitman, M., Patel, G., Schaefer, S., Iyer, K., et al. (2022) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 190
- Verified
Pathogenesis of Pulmonary Aspergillosis. Granulocytopenia Versus Cyclosporine and Methylprednisolone-Induced Immunosuppression
Berenguer, J., Allende, M. C., Lee, J. W., Garrett, K., Lyman, C., Ali, N. M., Bacher, J., Pizzo, P. A., & Walsh, T. J. (1995) · American journal of respiratory and critical care medicine
Antifungal resistance and susceptibilityImmunodeficiency and Autoimmune Disorders
Cited by 183
- Verified
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
Moriyama, B., Henning, S. A., Leung, J., Falade‐Nwulia, O., Jarosinski, P., Penzak, S. R., & Walsh, T. J. (2012) · Mycoses
Antifungal resistance and susceptibilityCancer Treatment and Pharmacology
Cited by 164
- Verified
Host-Dependent Patterns of Tissue Injury in Invasive Pulmonary Aspergillosis
Stergiopoulou, T., Meletiadis, J., Roilides, E., Kleiner, D. E., Schaufele, R., Roden, M., Harrington, S., Dad, L., Segal, B., & Walsh, T. J. (2007) · American Journal of Clinical Pathology
Antifungal resistance and susceptibilityNeutropenia and Cancer Infections
Cited by 152
- Verified
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
Pfaller, M. A., Andes, D., Arendrup, M. C., Diekema, D. J., Espinel-Ingroff, A., Alexander, B. D., Brown, S. D., Chaturvedi, V., Fowler, C. L., Ghannoum, M. A., et al. (2011) · Diagnostic Microbiology and Infectious Disease
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 130
- Verified
Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis
Groll, A. H., Wood, L., Roden, M., Mickiene, D., Chiou, C. C., Townley, E., Dad, L., Piscitelli, S. C., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityPharmaceutical studies and practices
Cited by 123
- Verified
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics
Antifungal resistance and susceptibilityPharmaceutical studies and practices
Cited by 120
- Verified
Synergy, Pharmacodynamics, and Time-Sequenced Ultrastructural Changes of the Interaction between Nikkomycin Z and the Echinocandin FK463 against Aspergillus fumigatus
Chiou, C. C., Mavrogiorgos, N., Tillem, E., Hector, R., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 117
- Verified
A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies
Gamaletsou, M. N., Walsh, T. J., Zaoutis, T., Pagoni, M., Kotsopoulou, M., Voulgarelis, M., Panayiotidis, P., Vassilakopoulos, T., Angelopoulou, M. K., Marangos, M., et al. (2014) · Clinical Microbiology and Infection
Antifungal resistance and susceptibilityNeutropenia and Cancer Infections
Cited by 112
- Verified
Homozygosity at the MTL locus in clinical strains of Candida albicans: karyotypic rearrangements and tetraploid formation†
Legrand, M., Lephart, P., Forche, A., Mueller, F. C., Walsh, T., Magee, P. T., & Magee, B. B. (2004) · Molecular Microbiology
Fungal and yeast genetics researchAntifungal resistance and susceptibility
Cited by 110
- Verified
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method
Gehrt, A., Peter, J., Pizzo, P. A., & Walsh, T. J. (1995) · Journal of Clinical Microbiology
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 105
- Verified
Differential Fungicidal Activities of Amphotericin B and Voriconazole against Aspergillus Species Determined by Microbroth Methodology
Meletiadis, J., Antachopoulos, C., Stergiopoulou, T., Pournaras, S., Roilides, E., & Walsh, T. J. (2007) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 100
- Verified
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis
Spec, A., Pullman, J., Thompson, G. R., Powderly, W. G., Tobin, E. H., Vazquez, J., Wring, S. A., Angulo, D., Helou, S., Pappas, P. G., et al. (2019) · Journal of Antimicrobial Chemotherapy
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 88
- Verified · note
Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation
Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing
Cited by 83
- Verified
Candida Epiglottitis in Immunocompromised Patients
Walsh, T. J., & Gray, W. C. (1987) · Chest
Antifungal resistance and susceptibilityOtolaryngology and Infectious Diseases
Cited by 71
- Verified
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants
Baysac, K., Sun, G., Nakano, H., Schmitz, E. G., Cruz, A. C., Fisher, C., Bailey, A. C., Abbott, J. K., Aldave Becerra, J. C., Allenspach, E. J., et al. (2024) · Journal of Allergy and Clinical Immunology
Immunodeficiency and Autoimmune DisordersT-cell and B-cell Immunology
Cited by 63
- Verified
Late Recurrent Candida Endocarditis
Johnston, P. G., Lee, J., Domunski, M., Dressler, F., Tucker, E., Rothenberg, M., Cunnion, R. E., Pizzo, P. A., & Walsh, T. J. (1991) · Chest
Infective Endocarditis Diagnosis and ManagementAntifungal resistance and susceptibility
Cited by 51
- Verified
Candidal Suppurative Peripheral Thrombophlebitis Recognition, Prevention, and Management
Walsh, T. J., Bustamente, C. I., Vlahov, D., & Standiford, H. C. (1986) · Infection Control
Antifungal resistance and susceptibilityCentral Venous Catheters and Hemodialysis
Cited by 43
- Verified
In Vitro Combination of Isavuconazole with Micafungin or Amphotericin B Deoxycholate against Medically Important Molds
Katragkou, A., McCarthy, M., Meletiadis, J., Petraitis, V., Moradi, P. W., Strauss, G. E., Fouant, M. M., Kovanda, L. L., Petraitiene, R., Roilides, E., et al. (2014) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 42
- Verified
Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies
Sfeir, M. M., Jiménez-Ortigosa, C., Gamaletsou, M. N., Schuetz, A. N., Soave, R., Van Besien, K., Small, C. B., Perlin, D. S., & Walsh, T. J. (2020) · Journal of Fungi
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free